TelyRx Holdings Inc.
TELY.TO
TSX
| 12/31/2025 | 09/30/2025 | 12/31/2024 | |||
|---|---|---|---|---|---|
| Net Income | -3.10M | -- | -893.00K | ||
| Total Depreciation and Amortization | 133.00K | -- | -32.00K | ||
| Total Amortization of Deferred Charges | 138.00K | -- | 187.00K | ||
| Total Other Non-Cash Items | 224.00K | -- | 793.00K | ||
| Change in Net Operating Assets | 2.18M | -- | -429.00K | ||
| Cash from Operations | -427.00K | -- | -374.00K | ||
| Capital Expenditure | -122.00K | -- | -68.00K | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | 250.00K | ||
| Other Investing Activities | -142.00K | -- | -566.00K | ||
| Cash from Investing | -264.00K | -- | -384.00K | ||
| Total Debt Issued | 2.00M | -- | 0.00 | ||
| Total Debt Repaid | -111.00K | -- | -182.00K | ||
| Issuance of Common Stock | -- | -- | 3.36M | ||
| Repurchase of Common Stock | 0.00 | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | 0.00 | ||
| Cash from Financing | 1.89M | -- | 3.18M | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 1.20M | -- | 2.42M | ||